Use of quetiapine in bipolar disorder: A case series with prospective evaluation

T. Suppes, S. L. McElroy, P. E. Keck, L. Altshuler, M. A. Frye, H. Grunze, G. S. Leverich, W. A. Nolen, K. Chisholm, E. B. Dennehy, R. M. Post

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Quetiapine, a new atypical antipsychotic, was added to ongoing treatment of bipolar I outpatients (n=15) for symptoms of illness (mood lability, irritability, psychosis and/ or difficulty sleeping). All evaluations were prospectively obtained, with the majority of patients (n=9) showing much or very much improvement on the Clinical Global Impression for Bipolar Disorder (CGI-BP). Somatic complaints were limited. Mean (SD) duration before changes in medication regimens was 134 (100) days. Studies of the use of quetiapine in maintenance treatment of bipolar disorder are warranted.

Original languageEnglish (US)
Pages (from-to)173-174
Number of pages2
JournalInternational Clinical Psychopharmacology
Volume19
Issue number3
DOIs
StatePublished - May 1 2004

    Fingerprint

Keywords

  • Bipolar disorder
  • Maintenance
  • Outpatient
  • Polypharmacy
  • Quetiapine
  • Treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Suppes, T., McElroy, S. L., Keck, P. E., Altshuler, L., Frye, M. A., Grunze, H., Leverich, G. S., Nolen, W. A., Chisholm, K., Dennehy, E. B., & Post, R. M. (2004). Use of quetiapine in bipolar disorder: A case series with prospective evaluation. International Clinical Psychopharmacology, 19(3), 173-174. https://doi.org/10.1097/00004850-200405000-00010